GB0909441D0 - Novel indole derivatives - Google Patents

Novel indole derivatives

Info

Publication number
GB0909441D0
GB0909441D0 GBGB0909441.8A GB0909441A GB0909441D0 GB 0909441 D0 GB0909441 D0 GB 0909441D0 GB 0909441 A GB0909441 A GB 0909441A GB 0909441 D0 GB0909441 D0 GB 0909441D0
Authority
GB
United Kingdom
Prior art keywords
indole derivatives
novel indole
novel
derivatives
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0909441.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Priority to GBGB0909441.8A priority Critical patent/GB0909441D0/en
Publication of GB0909441D0 publication Critical patent/GB0909441D0/en
Priority to PCT/GB2010/050896 priority patent/WO2010139982A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0909441.8A 2009-06-02 2009-06-02 Novel indole derivatives Ceased GB0909441D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0909441.8A GB0909441D0 (en) 2009-06-02 2009-06-02 Novel indole derivatives
PCT/GB2010/050896 WO2010139982A1 (en) 2009-06-02 2010-05-28 Indole derivatives for the stimulation of stem cell proliferation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0909441.8A GB0909441D0 (en) 2009-06-02 2009-06-02 Novel indole derivatives

Publications (1)

Publication Number Publication Date
GB0909441D0 true GB0909441D0 (en) 2009-07-15

Family

ID=40902443

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0909441.8A Ceased GB0909441D0 (en) 2009-06-02 2009-06-02 Novel indole derivatives

Country Status (2)

Country Link
GB (1) GB0909441D0 (en)
WO (1) WO2010139982A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012154967A1 (en) 2011-05-12 2012-11-15 Proteostasis Therapeutics, Inc. Proteostasis regulators
EP2948447B1 (en) 2013-01-23 2016-09-21 Astrazeneca AB Chemical compounds
WO2015073528A1 (en) 2013-11-12 2015-05-21 Proteostasis Therapeutics, Inc. Proteasome activity enhancing compounds
WO2016112088A1 (en) * 2015-01-06 2016-07-14 Spero Therapeutics, Inc. Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors
WO2020059841A1 (en) * 2018-09-21 2020-03-26 国立大学法人 長崎大学 Therapeutic agent for prion diseases
CN113603694B (en) * 2021-07-16 2022-07-22 浙江工业大学 1, 2-diketone compound and preparation method and application thereof
CN115317480B (en) * 2022-09-01 2023-05-16 新乡医学院 Pharmaceutical application of N-(3-methyl-5-isothiazolyl)-2-oxo-3-(2H)-benzoxazole acetamide
AU2023406476A1 (en) 2022-12-02 2025-06-05 Neumora Therapeutics, Inc. Methods of treating neurological disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192770A (en) * 1990-12-07 1993-03-09 Syntex (U.S.A.) Inc. Serotonergic alpha-oxoacetamides
DE19814838C2 (en) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylic acid derivatives with anti-tumor effects
AU2005304952B2 (en) * 2004-11-08 2013-04-04 Baxter Healthcare S.A. Nanoparticulate compositions of tubulin inhibitors
EP1865949B1 (en) * 2005-03-11 2012-11-14 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
JP2009517085A (en) * 2005-11-28 2009-04-30 チョンウェ ファーマ コーポレイション Serum-free growth of cells in culture
GB0701426D0 (en) * 2007-01-25 2007-03-07 Univ Sheffield Compounds and their use

Also Published As

Publication number Publication date
WO2010139982A1 (en) 2010-12-09

Similar Documents

Publication Publication Date Title
GB0905328D0 (en) Indole derivatives
ZA201203205B (en) Benzimidazole-imidazole derivatives
IL217956A0 (en) N1-sulfonyl-5-fluoropyrimidinone derivatives
IL217953A0 (en) 5-fluoropyrimidinone derivatives
IL220616A0 (en) Novel 3 - hydroxy - 5 - arylisothiazole derivative
EP2412708A4 (en) Substituted 3-hydroxy-4-pyridone derivative
EP2514747A4 (en) Substituted aminothiazine derivative
EP2495238A4 (en) Novel 3-hydroxy-5-arylisoxazole derivative
IL216007A0 (en) Isoxazole-pyridine derivatives
IL207684A0 (en) Substituted indole derivatives
IL215109A0 (en) Isoxazole-pyridazine derivatives
ZA201106855B (en) Oxasiazole derivatives
IL214941A0 (en) Isoxazole-pyrazole derivatives
IL210613A0 (en) Novel acylaminobenzamide derivatives
IL217952A0 (en) N1-acyl-5-fluoropyrimidinone derivatives
IL213927A0 (en) Deoxyactagardine derivatives
IL216761A0 (en) Pyrazinooxazepine derivatives
GB0909441D0 (en) Novel indole derivatives
IL225393A0 (en) Indole derivatives
GB0921967D0 (en) Novel Aryloxyanilide Derivatives
ZA201104279B (en) Tetrahydronaphthalen-2-ol derivatives
GB0912499D0 (en) Indopyl-pyridone derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)